261 related articles for article (PubMed ID: 27019254)
21. Chromium as adjunctive treatment for type 2 diabetes.
Ryan GJ; Wanko NS; Redman AR; Cook CB
Ann Pharmacother; 2003 Jun; 37(6):876-85. PubMed ID: 12773078
[TBL] [Abstract][Full Text] [Related]
22. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial.
Singer GM; Geohas J
Diabetes Technol Ther; 2006 Dec; 8(6):636-43. PubMed ID: 17109595
[TBL] [Abstract][Full Text] [Related]
23. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients.
Rabinovitz H; Friedensohn A; Leibovitz A; Gabay G; Rocas C; Habot B
Int J Vitam Nutr Res; 2004 May; 74(3):178-82. PubMed ID: 15296075
[TBL] [Abstract][Full Text] [Related]
24. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
25. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Pei D; Hsieh CH; Hung YJ; Li JC; Lee CH; Kuo SW
Metabolism; 2006 Jul; 55(7):923-7. PubMed ID: 16784965
[TBL] [Abstract][Full Text] [Related]
26. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis.
Fazelian S; Rouhani MH; Bank SS; Amani R
J Trace Elem Med Biol; 2017 Jul; 42():92-96. PubMed ID: 28595797
[TBL] [Abstract][Full Text] [Related]
27. MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Krul-Poel YH; Ter Wee MM; Lips P; Simsek S
Eur J Endocrinol; 2017 Jan; 176(1):R1-R14. PubMed ID: 27484453
[TBL] [Abstract][Full Text] [Related]
28. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats.
Lai MH; Chen YY; Cheng HH
Int J Vitam Nutr Res; 2006 Nov; 76(6):391-7. PubMed ID: 17607959
[TBL] [Abstract][Full Text] [Related]
29. Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials.
Ursoniu S; Sahebkar A; Serban MC; Antal D; Mikhailidis DP; Cicero A; Athyros V; Rizzo M; Rysz J; Banach M;
Nutr Rev; 2017 May; 75(5):361-373. PubMed ID: 28371906
[TBL] [Abstract][Full Text] [Related]
30. Favorable effects on metabolic risk factors with daily brewer's yeast in type 2 diabetic patients with hypercholesterolemia: a semi-experimental study.
Khosravi-Boroujeni H; Rostami A; Ravanshad S; Esmaillzadeh A
J Diabetes; 2012 Jun; 4(2):153-8. PubMed ID: 22018047
[TBL] [Abstract][Full Text] [Related]
31. Is chromium supplementation effective in managing type II diabetes?
Hellerstein MK
Nutr Rev; 1998 Oct; 56(10):302-6. PubMed ID: 9810809
[TBL] [Abstract][Full Text] [Related]
32. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
Pirro M; Mannarino MR; Bianconi V; Simental-Mendía LE; Bagaglia F; Mannarino E; Sahebkar A
Pharmacol Res; 2016 Aug; 110():76-88. PubMed ID: 27157250
[TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis.
Vidal-Casariego A; Burgos-Peláez R; Martínez-Faedo C; Calvo-Gracia F; Valero-Zanuy MÁ; Luengo-Pérez LM; Cuerda-Compés C
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):234-8. PubMed ID: 23430574
[TBL] [Abstract][Full Text] [Related]
34. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
35. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
[TBL] [Abstract][Full Text] [Related]
36. Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis.
Tang XL; Sun Z; Gong L
J Obstet Gynaecol Res; 2018 Jan; 44(1):134-143. PubMed ID: 28929602
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status.
Bahijri SM; Mufti AM
Biol Trace Elem Res; 2002 Feb; 85(2):97-109. PubMed ID: 11899964
[TBL] [Abstract][Full Text] [Related]
38. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Visser J; Snel M; Van Vliet HA
Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193
[TBL] [Abstract][Full Text] [Related]
39. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials.
Kleefstra N; Houweling ST; Bilo HJ
Diabetes Care; 2007 Sep; 30(9):e102; author reply e103. PubMed ID: 17726181
[No Abstract] [Full Text] [Related]
40. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.
Wulffelé MG; Kooy A; de Zeeuw D; Stehouwer CD; Gansevoort RT
J Intern Med; 2004 Jul; 256(1):1-14. PubMed ID: 15189360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
